Genmab — November 2019
-
Hvad er omsætningen?
-
På yahoo men ved ikke om man kan stole på det https://finance.yahoo.com/quote/GMAB/key-statistics?p=GMAB
-
PRAC agenda - Scope: Extension application to introduce a new pharmaceutical form (solution for
injection), a new strength (1800 mg) and a new route of administration (subcutaneous
route). The RMP (version 7.0) is updated accordingly
Action: For adoption of PRAC RMP AR, PRAC RMP assessment overview and advice to CHMP https://www.ema.europa.eu/en/documents/agenda/agenda-prac-draft-agenda-meeting-25-28-november-2019_en.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind